119 related articles for article (PubMed ID: 35236269)
1. Mucocutaneous Manifestations of People Living with HIV in Current Antiretroviral Therapy Era.
Sivaz O; Ozkur E; Altunay IK; Oncul A; Sevgi DY
Curr HIV Res; 2022 Aug; 20(2):120-128. PubMed ID: 35236269
[TBL] [Abstract][Full Text] [Related]
2. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
Nnoruka EN; Chukwuka JC; Anisuiba B
Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
[TBL] [Abstract][Full Text] [Related]
3. Association of cutaneous and oral diseases in HIV-infected men.
Mirowski GW; Hilton JF; Greenspan D; Canchola AJ; MacPhail LA; Maurer T; Berger TG; Greenspan JS
Oral Dis; 1998 Mar; 4(1):16-21. PubMed ID: 9655039
[TBL] [Abstract][Full Text] [Related]
4. Mucocutaneous manifestations in human immunodeficiency virus (HIV)-infected patients in Nouakchott, Mauritania.
Boushab BM; Malick Fall FZ; Ould Cheikh Mohamed Vadel TK; Ould Cheikh Melaïnine ML; Maazouz MV; Savadogo M; Basco LK
Int J Dermatol; 2017 Dec; 56(12):1421-1424. PubMed ID: 28960268
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Features of Seborrheic-Like Dermatitis in HIV-Infected Adults: A Single Institutional Descriptive Cross-Sectional Study.
Mahlangeni GM; Tod BM; Jordaan HF; Schneider JW
Am J Dermatopathol; 2021 Jan; 43(1):27-34. PubMed ID: 32379092
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
[TBL] [Abstract][Full Text] [Related]
7. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China.
Li YY; Yang SH; Wang RR; Tang JT; Wang HM; Kuang YQ
Int J Dermatol; 2020 Mar; 59(3):308-313. PubMed ID: 31846069
[TBL] [Abstract][Full Text] [Related]
8. Dermatologic manifestations among human immunodeficiency virus patients in Morocco and association with immune status.
Titou H; Ebongo C; Hjira N
Int J Dermatol; 2018 Feb; 57(2):156-161. PubMed ID: 29243825
[TBL] [Abstract][Full Text] [Related]
9. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand.
Sivayathorn A; Srihra B; Leesanguankul W
Ann Acad Med Singap; 1995 Jul; 24(4):528-33. PubMed ID: 8849182
[TBL] [Abstract][Full Text] [Related]
11. Dermatological lesions among people living with HIV in Turkey.
Mustafayev K; Mete B; Kutlubay Z; Tanakol A; Şahin Özdemir M; Garashova D; Balkan İİ; Saltoglu N; Tabak ÖF
Int J STD AIDS; 2022 Jan; 33(1):55-62. PubMed ID: 34565234
[TBL] [Abstract][Full Text] [Related]
12. Correlation of mucocutaneous manifestations of HIV-infected patients in an ART center with CD4 counts.
Lahoti S; Rao K; Umadevi HS; Mishra L
Indian J Dent Res; 2017; 28(5):549-554. PubMed ID: 29072219
[TBL] [Abstract][Full Text] [Related]
13. Mucocutaneous manifestations of HIV-infected patients in the era of HAART in Guangxi Zhuang Autonomous Region, China.
Han J; Lun WH; Meng ZH; Huang K; Mao Y; Zhu W; Lian S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):376-82. PubMed ID: 22212015
[TBL] [Abstract][Full Text] [Related]
14. Histopathological study of cutaneous manifestations in HIV and AIDS patients.
Rane SR; Agrawal PB; Kadgi NV; Jadhav MV; Puranik SC
Int J Dermatol; 2014 Jun; 53(6):746-51. PubMed ID: 24320966
[TBL] [Abstract][Full Text] [Related]
15. Mucocutaneous Manifestations in HIV-Infected Patients and Their Relationship to CD4 Lymphocyte Counts.
Mirnezami M; Zarinfar N; Sofian M; Botlani Yadegar B; Rahimi H
Scientifica (Cairo); 2020; 2020():7503756. PubMed ID: 32850174
[TBL] [Abstract][Full Text] [Related]
16. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.
Phillips A; Pezzotti P;
AIDS; 2004 Jan; 18(1):51-8. PubMed ID: 15090829
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count.
Fernandes MS; Bhat RM
Int J STD AIDS; 2015 May; 26(6):414-9. PubMed ID: 25015936
[TBL] [Abstract][Full Text] [Related]
18. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.
Duggal MS; Abudiak H; Dunn C; Tong HJ; Munyombwe T
Eur Arch Paediatr Dent; 2010 Oct; 11(5):242-6. PubMed ID: 20932399
[TBL] [Abstract][Full Text] [Related]
19. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon.
Josephine M; Issac E; George A; Ngole M; Albert SE
Int J Dermatol; 2006 Mar; 45(3):280-4. PubMed ID: 16533229
[TBL] [Abstract][Full Text] [Related]
20. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
